Back to Search Start Over

Timing of cardioverter-defibrillator implantation in patients with cardiac laminopathies—External validation of the LMNA-risk ventricular tachyarrhythmia calculator.

Authors :
Rootwelt-Norberg, Christine
Christensen, Alex Hørby
Skjølsvik, Eystein T.
Chivulescu, Monica
Vissing, Christoffer R.
Bundgaard, Henning
Aabel, Eivind W.
Bogsrud, Martin P.
Hasselberg, Nina E.
Lie, Øyvind H.
Haugaa, Kristina H.
Source :
Heart Rhythm; Mar2023, Vol. 20 Issue 3, p423-429, 7p
Publication Year :
2023

Abstract

LMNA genotype-positive patients have high risk of experiencing life-threatening ventricular tachyarrhythmias (VTAs). The LMNA -risk VTA calculator published in 2019 has not been externally validated. The purpose of this study was to validate the LMNA -risk VTA calculator. We included LMNA genotype-positive patients without previous VTAs from 2 large Scandinavian centers. Patients underwent electrocardiography, 24-hour Holter monitoring, and echocardiographic examinations at baseline and repeatedly during follow-up. Validation of the LMNA -risk VTA calculator was performed using Harrell's C-statistic derived from multivariable Cox regression analysis. We included 118 patients (age 37 years [IQR 27–49 years]; 39 [33%] probands; 65 [55%] women; 100 [85%] with non-missense LMNA variants). Twenty-three patients (19%) experienced VTA during 6.1 years (interquartile range 3.0–9.1 years) follow-up, resulting in 3.0% (95% confidence interval 2.0%–4.5%) yearly incidence rate. Atrioventricular block and reduced left ventricular ejection fraction were independent predictors of VTAs, while nonsustained ventricular tachycardia, male sex, and non-missense LMNA variants were not. The LMNA -risk VTA calculator showed 83% sensitivity and 26% specificity for identifying patients with VTAs during the coming 5 years, and a Harrell's C-statistic of 0.85, when applying ≥7% predicted 5-year VTA risk as threshold. The sensitivity increased to 100% when reevaluating risk at the time of last consultation before VTA. The calculator overestimated arrhythmic risk in patients with mild and moderate phenotype, particularly in men. Validation of the LMNA -risk VTA calculator showed high sensitivity for subsequent VTAs, but overestimated arrhythmic risk when using ≥7% predicted 5-year risk as threshold. Frequent reevaluation of risk was necessary to maintain the sensitivity of the model. [Display omitted] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15475271
Volume :
20
Issue :
3
Database :
Supplemental Index
Journal :
Heart Rhythm
Publication Type :
Academic Journal
Accession number :
161844176
Full Text :
https://doi.org/10.1016/j.hrthm.2022.11.024